Abstract
The indications for surgery on cavernous hemangiomas, the most common benign tumors of the liver, remain unclear. This study reviewed 43 patients with cavernous hemangioma of the liver who underwent hepatic resection from 1984 to 2000. Patients were divided into three groups based on the reasons for surgery. Group I comprised 13 patients whose lesions presented symptoms and dimensions that were the main indications for operation. Group II consisted of 28 patients diagnosed with malignant tumors or who displayed malignant growth that could not be ruled out preoperatively. Group III comprised 2 patients with tumors found incidentally at laparotomy for other malignancies. No surgical mortality related to hepatectomy was noted. Postoperative bile leak was found in 2 (morbidity rate: 4.7%). Patients were followed up from 6 months to 12 years. Thirteen residual tumors progressed in size. The clinical status or symptoms changed only slightly in 10 patients with recurrence. The results suggest that resection therapy is an effective indicator for patients with symptoms and a questionable diagnosis. Hepatic resection may and should be carried out with no mortality and minimal morbidity risks since the lesion is benign.
Similar content being viewed by others
References
Nichols FC, van Heerden JA, Weiland LH: Benign liver turnor. Surg Clin North Am 69:297-314, 1989
Feldman M: Hemangioma of the liver. Am J Clin Pathol 29:160-162, 1958
Gaudolfi L, Leo P, Solmi L: Natural history of hepatic hemangioma: Clinical and ultrasound study. Gut 38:677-680, 1991
Schwartz SI, Husse WC: Cavernous hemangioma of the liver. A single institution report of 16 resections. Ann Surg 205:456-463, 1987
Sinanan M, Marchioro T: Management of cavernous hemangioma of the liver. Am J Surg 157:519-522, 1989
Kawarda Y, Mizumoto R: Surgical treatment of giant hemangioma of the liver. Am J Surg 148:287-291, 1984
Peveretos P, Panoussopoulos D: Giant cavernous hepatic hemangioma: Treatment by ligation of the hepatic artery. J Surg Oncol 31:48-51, 1986
Park WC, Phollips R: The role of radiation therapy in the management of hemangiomas of the liver. JAMA 212:1496-1498, 1970
Issa P: Cavernous hemangioma of the liver: the role of radiotherapy. Br J Radiol 41:26-32, 1968
Trastek VF, van Heerden JA, Sheedy PF II,et al: Cavernous hemangioma of the liver: resect or observe? Am J Surg 145:49-53, 1983
Yamagato M, Kanematsu T, Matsumata T,et al: Comparison of results between surgery and observation. Br J Surg 78:1223-1225, 1991
Belli L, De Carlis L, Beati C,et al: Surgical treatment of symptomatic giant hemangioma of the liver. Surg Gynecol Obstet 174:474-478, 1992
Sung JL, Wang TH, Yu JY: Clinical study on primary carcinoma of the liver in Taiwan. Am J Dig Dis 12:1036-1049, 1967
Chen MF, Hwang TL, Jeng LB,et al: Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 124:1025-1028, 1989
Beasley RP, Hwang LY, Lin CC,et al: Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 21:1129-1133, 1981
Liaw YF, Lin, DY, Chen TJ,et al: Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver 9:235-241, 1989
Di Bisceglie, AM: Hepatitis C and hepatocellular carcinoma. Hepatology 26:34s-38s, 1997
Chen CJ, Yu MW, Liaw YF: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastro Hepato 12:294-308, 1997
Simonetti R, Camma C, Fiorello F,et al: Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36:962-972, 1991
Obata H, Hatashi N, Motoike Y,et al: A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 25:741, 1980
Freeny DC, Marks WM: Patterns of contrast enhancement of benign and malignant hepatic neoplasm durning bolus dynamic and delayed CT. Radiology 160:613-618, 1986
Nelson RC, Chezmar JL: Diagnostic approach to hepatic hemangiomas. Radiology 176:11-13, 1990
Gandolfi L, Leo P, Solmi L,et al: Nature history of hepatic hemangiomas: Clinical and ultrasound study. Gut 32:677-680, 1991
Ashida C, Fishman EK, Zerhouni EA,et al: Computed tomography of hepatic cavernous hemangioma. J Comput Assist Tomo 11:455-460, 1987
Stark DD, Felder RC, Wittenberg J,et al: Magnetic resonance imaging of cavernous hemangioma of the liver; tissue-specific characterization. AJR 145:213-222, 1985
Krausz Y, Levy P, Antebi E,et al: Liver hemangioma. A prospective Tc-99m RBC SPECT correlation. Clin Nucl Med 22:35-37, 1997
Intenzo C, Kim S, Madsen M,et al: Planar and SPECT Tc-99m red blood cell imaging in hepatic cavernous hemangiomas and other hepatic lesions. Clin Nucl Med 13:237-240, 1988
Gonzalez-Anon M, Cervera-Deval J, Garcia Vila JH,et al: Characterization of solid liver lesions with color and pulsed Doppler imaging. Abdominal Imaging 24:137-143, 1999
Alper A, Ariogui O, Emre A,et al: Treatment of liver hemangiomas by enucleation. Arch Surg 132:660-661, 1988
Gedaly R, Pomposelli JJ, Pomfret EA,et al: Cavernous hemangion of the liver: Anatomic resection vs. enucleation. Arch Surg 134:407-411, 1999
Yamagata M, Kanematsu T, Matsumata T,et al: Management of hemangioma of the liver: comparison of results between surgery and observation. Br J Surg 78:1223-1225, 1991
Chen MF, Jeng LB, Lee WC,et al: Surgical results in patients with dual hepatitis B-and C-related hepatocellular carcinoma compared with patients B-or C-related hepatocellular carcinoma. Surgery 123:554-559, 1998
Starzl TE, Koep LJ, Weil R,et al: Excisional treatment of cavernous hemangioma of the liver. Ann Surg 192:25-27, 1980
Jeng LB, Chen SC, Hwang TS,et al: Resectional therapy for a giant cavernous hemangioma of the liver. Chang Gung Med J 17:325-332, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsai, HP., Jeng, LB., Lee, WC. et al. Clinical Experience of Hepatic Hemangioma Undergoing Hepatic Resection. Dig Dis Sci 48, 916–920 (2003). https://doi.org/10.1023/A:1023099529229
Issue Date:
DOI: https://doi.org/10.1023/A:1023099529229